The Latest in B-Cell Lymphoma ICYMI

Circadian rhythm changes linked to future Parkinson’s disease risk

June 23, 2020

FDA gives thumbs up to tazemetostat for follicular lymphoma

June 19, 2020

New EPOCH for adult patients with Burkitt lymphoma

June 17, 2020

B Cell Lymphoma

Relapsing, progressive MS classifications should be abandoned

June 16, 2020

FDA approves Uplizna for treatment of anti-AQP4 antibody–positive NMOSD

June 15, 2020

Three-drug combo promising against high-risk CLL

June 15, 2020

CLL

American Cancer Society update: ‘It is best not to drink alcohol’

June 9, 2020

B Cell Lymphoma

Huntington’s disease biomarkers appear 24 years before clinical symptoms

June 5, 2020

Adding avadomide shows promise for newly diagnosed DLBCL

June 5, 2020

COVID-19 neurologic effects: Does the virus directly attack the brain?

June 5, 2020

Added rituximab was effective in children and adolescents with high-risk B-cell NHL

June 3, 2020

B Cell Lymphoma

MCC response varies based on immunosuppression type, especially CLL

June 2, 2020

CLL

Neurologists’ pay gets a boost, most happy with career choice

May 22, 2020

Framingham risk score may also predict cognitive decline

May 21, 2020

AAN publishes ethical guidance on patient care during the pandemic

May 20, 2020